INTERNATIONAL PATENT: NANJING HUILI BIOTECHNOLOGY CO., LTD., 南京晖丽生物科技有限公司 FILES APPLICATION FOR "USE OF MIR-3120 AND ANALOG THEREOF IN PREVENTION AND TREATMENT OF TUMOR AND TUMOR CACHEXIA"

GENEVA, Dec. 7 -- NANJING HUILI BIOTECHNOLOGY CO., LTD. (Room 1703, Building 1, No. 88, The Zhujiang Road, Xuanwu DistrictNanjing, Jiangsu 210018), 南京晖丽生物科技有限公司 (中国江苏省南京市玄武区珠江路88号1幢1703室) filed a patent application (PCT/CN2024/099663) for "USE OF MIR-3120 AND ANALOG THEREOF IN PREVENTION AND TREATMENT OF TUMOR AND TUMOR CACHEXIA" on Jun 17, 2024. With publication no. WO/2025/245933, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classi...